Thoraflex™ Hybrid THP2830X100ARecalls & reported problems
Vascutek Ltd · Thoraflex Hybrid Plexus 4 Hybrid Stent Device · Class 3 · Implant
All models of Thoraflex Hybrid (33)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 05037881026718), received between May 22, 2024 and Apr 24, 2025 — classified as 4 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information3
- Human-Device Interface Problem1
- Obstruction of Flow1
- Patient-Device Incompatibility1
Patient problems
- Thrombosis/Thrombus2
- Insufficient Information1
- Ischemia1
- Obstruction/Occlusion1
- Rupture1
- Vascular Dissection1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryApr 24, 2025Insufficient Device Problem Information; Insufficient Device Problem Information
ON POST OPERATIVE DAY 4 ((B)(6) 2025), SITE REPORTED AN ADVERSE EVENT (AE) OF FALSE LUMEN THROMBOSED, WITH IMPROVED EXPANDED TRUE LUMEN EXTENDING FROM THE PROXIMAL ASCENDING AORTA TO THE PROXIMAL ABDOMINAL AORTA, AT THE LEVEL OF L1 VERTEBRAL BODY. PATIENT OUTCOME: THE THROMBOSIS IS ONGOING, UNRESOLVED WITH NO TREATMENT AND IS ONGOING AT TIME OF REPORTING. THE ADVERSE EVENT IS CONSIDERED MODERATE IN SEVERITY. THE SUBJECT CONTINUED IN THE STUDY. CONCOMITANT MEDICATIONS INCLUDE ASPIRIN, LABETALOL AND NICARDIPINE.
Patient problems: Thrombosis/Thrombus
MAUDE report 21897697 ↗InjuryFeb 18, 2025Patient-Device Incompatibility; Insufficient Device Problem Information; Patient-Device Incompatibility; Insufficient Device Problem Information
PATIENT IS PART OF CLINICAL TRIAL (B)(6). THE ONLY INFORMATION THAT SITE HAVE ENTERED INTO THE EDC (ELECTRONIC DATA CAPTURE SYSTEM) IS THE EVENT TERM, START DATE OF THE EVENT. THE SITE WILL BE REQUESTED TO UPDATE THE ADVERSE EVENT PAGE AND ANY RELEVANT PAGES IN THE EDC. ON (B)(6) 2024 THE PATIENT DEVELOPED THE MEDICAL EVENT OF A STENT GRAFT INDUCED NEW ENTRY (SINE) THIS REPORT IS BEING SUBMITTED AS FOLLOW UP # 1 FOR MANUFACTURING REPORT 9612515-2025-00017 TO PROVIDE EVENT CLOSURE INFORMATION FOR (B)(4).
Patient problems: Insufficient Information; Rupture
MAUDE report 21397946 ↗InjuryAug 28, 2024Human-Device Interface Problem; Insufficient Device Problem Information; Human-Device Interface Problem; Insufficient Device Problem Information
EVENT REPORTED: 06 AUG 24. IMPLANT DATE: (B)(6) 2024. EXTEND-OO1 (NCT05639400) POST MARKET APPROVAL STUDY. EVENT DETAILS AS REPORTED, THE PATIENT THROMBUS IN ASCENDING AORTA SEEN WITH COMPRESSION INTO LEFT ATRIUM. THE THROMBUS OCCURRED OF (B)(6) 2024. THORAFLEX HYBRID WAS IMPLANTED ON (B)(6) 2024. NO DISTAL SEAL WAS INTENDED DUE TO A PLANNED EVAR EXTENSION AND NO DISTAL SEAL WAS OBTAINED. NO ENDOLEAK WAS PRESENT AT THE END OF THE PROCEDURE. DELIVERY OF THE THORAFLEX HYBRID WAS SUCCESSFUL, DEPLOYED IN PLANNED LOCATION AND WITHDRAWAL OF DELIVERY SYSTEM WAS SUCCESSFUL. NO DEVICE DEFICIENCIES OCCURRED DURING THE INDEX TH PROCEDURE. THE CLINICIAN/SITE HAVE REPORTED THIS EVENT AS NOT RELATED TO DEVICE AND POSSIBLY RELATED TO PRE-EXISTING CONDITION; RELATIONSHIP TO PROCEDURE NOT PROVIDED AS YET. DURING THEIR REGULAR REVIEW OF EXTEND ADVERSE EVENTS, THE STUDY MEDICAL MONITOR HAS REVIEWED AND MARKED THIS EVENT AS POSSIBLY RELATED TO THE DEVICE AND POSSIBLY RELATED TO PROCEDURE. THE SITE HAVE INDICATED THAT NO ACTION HAS BEEN TAKEN TO TREAT THE ADVERSE EVENT AT THIS TIME. PATIENT CURRENT STATUS IS UNRESOLVED AT THIS TIME.
Patient problems: Ischemia; Thrombosis/Thrombus
MAUDE report 20083382 ↗InjuryMay 22, 2024Obstruction of Flow; Obstruction of Flow
AS REPORTED: THE PATIENT HAD A SURGERY FOR A TOTAL ARCH REPAIR. THE PHYSICIAN SAID HIS TRUE LUMEN WAS OCCLUDED AND THEY WERE GOING BACK TO EXTEND THE THORAFLEX IN A LAST-DITCH EFFORT CTA (COMPUTED TOMOGRAPHY ANGIOGRAPHY) WAS PERFORMED IT WAS CLEAR THAT A DISTAL NEW STENT ENTRY TEAR WAS PRESENT. THE PATIENT UNDERWENT ANOTHER SURGERY TO EXTEND THE THORAFLEX AND SEAL OFF THE ANEURYSM USING A COOK MEDICAL DISSECTION GRAFT (TX2), AS WELL AS PERFORM A THROMBECTOMY ON THE SUPERIOR MESENTERIC ARTERY, AS IT WAS COMPLETELY THROMBOSED. A COOK MEDICAL DISSECTION STENT WAS PLACED FROM THE COOK MEDICAL TX2 THORAFLEX EXTENSION TO THE BIFURCATION AND A KNICKER BOCKER TECHNIQUE WAS PERFORMED IN THE ZDEG (ZENITH DISSECTION ENDOVASCUALR GRAFT) USING A 46MM CODA BALLOON. THE DISSECTION WAS THEN STABILIZED USING THE SAME CODA BALLOON, THROUGH THE ZDES (ZENITH DISSECTION ENDOVASCULAR STENT). THE SUPERIOR MESENTERIC ARTERY, THE RIGHT RENAL ARTERY, AND LEFT RENAL ARTERY WERE STENTED SO ALL VITAL ORGANS COULD BE PERFUSED. THE LOWER EXTREMITIES AT THIS TIME ALSO WERE NOT BEING PERFUSED, THEREFORE GORE EXCLUDER LIMBS WERE PLACED AS "KISSING STENTS" FROM THE BILATERAL HYPOGASTRIC ARTERIES TO THE INFRARENAL AO
Patient problems: Obstruction/Occlusion; Vascular Dissection
MAUDE report 19368647 ↗
Other Hybrid stent graft, thoracic aortic lesion treatment devices
- Thoraflex™ Hybrid THP3032X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment3 deaths8 reports
- Thoraflex™ Hybrid THP3036X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment7 reports
- Thoraflex™ Hybrid THP3032X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THA3036X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THP3036X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment1 death3 reports
- Thoraflex™ Hybrid THA3032X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment2 deaths3 reports
- Thoraflex™ Hybrid THA2830X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment1 death3 reports
- Thoraflex™ Hybrid THA3034X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page